BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38043731)

  • 1. Medicinal Chemistry and NMR Driven Discovery of Novel UDP-glucuronosyltransferase 1A Inhibitors That Overcome Therapeutic Resistance in Cells.
    Osborne MJ; Sulekha A; Culjkovic-Kraljacic B; Gasiorek J; Ruediger E; Jolicouer E; Marinier A; Assouline S; Borden KLB
    J Mol Biol; 2024 Jan; 436(2):168378. PubMed ID: 38043731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.
    Osborne MJ; Coutinho de Oliveira L; Volpon L; Zahreddine HA; Borden KLB
    J Mol Biol; 2019 Jan; 431(2):258-272. PubMed ID: 30428301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
    Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes.
    Fujiwara R; Nakajima M; Oda S; Yamanaka H; Ikushiro S; Sakaki T; Yokoi T
    J Pharm Sci; 2010 Jan; 99(1):442-54. PubMed ID: 19475557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of functional UDP-glucuronosyltransferases 1A and 2B in common marmosets.
    Uno Y; Uehara S; Inoue T; Kawamura S; Murayama N; Nishikawa M; Ikushiro S; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2020 Feb; 172():113748. PubMed ID: 31830470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A).
    Osborne MJ; Coutinho de Oliveira L; Volpon L; Borden KLB
    Biomol NMR Assign; 2018 Oct; 12(2):315-318. PubMed ID: 29934866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
    Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T
    Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine.
    Assouline S; Gasiorek J; Bergeron J; Lambert C; Culjkovic-Kraljacic B; Cocolakis E; Zakaria C; Szlachtycz D; Yee K; Borden KLB
    Haematologica; 2023 Nov; 108(11):2946-2958. PubMed ID: 36951168
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sulekha A; Osborne MJ; Gasiorek J; Borden KLB
    Biomol NMR Assign; 2023 Jun; 17(1):67-73. PubMed ID: 36757531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
    Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
    Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
    Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
    Miners JO; Chau N; Rowland A; Burns K; McKinnon RA; Mackenzie PI; Tucker GT; Knights KM; Kichenadasse G
    Biochem Pharmacol; 2017 Apr; 129():85-95. PubMed ID: 28065859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques.
    Uno Y; Takahira R; Murayama N; Ishii Y; Ikenaka Y; Ishizuka M; Yamazaki H; Ikushiro S
    Biochem Pharmacol; 2018 Sep; 155():172-181. PubMed ID: 29944869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
    Lu L; Zhou J; Shi J; Peng XJ; Qi XX; Wang Y; Li FY; Zhou FY; Liu L; Liu ZQ
    PLoS One; 2015; 10(5):e0127524. PubMed ID: 26010150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
    Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
    Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells.
    Liu M; Wang Q; Liu F; Cheng X; Wu X; Wang H; Wu M; Ma Y; Wang G; Hao H
    PLoS One; 2013; 8(11):e79172. PubMed ID: 24244442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
    Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
    Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
    Strassburg CP; Nguyen N; Manns MP; Tukey RH
    Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monospecific antipeptide antibodies against human hepatic UDP-glucuronosyltransferase 1A subfamily (UGT1A) isoforms.
    Ikushiro S; Emi Y; Kato Y; Yamada S; Sakaki T
    Drug Metab Pharmacokinet; 2006 Feb; 21(1):70-4. PubMed ID: 16547396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.